It opened a UK office at Manchester Science Park in February this year and has acquired UK-based CHAPPER healthcare, a family-owned leading global pharmaceutical distributor and wholesaler ...

The Toho Group already has a 45 percent share of the Japanese distribution market. Earlier, Toho an made a $225 million equity investment in Los Angeles-based production and distribution company ...

“As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the ...

Distribution and use of this material are ... are looking for alternatives as geopolitical tensions rise. From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

As much as anything, I believe that SentinelOne's recent struggles are more a distribution issue, but the company has been presented with an opportunity in this regard. I previously suggested that ...

Your small business can choose from a variety of distribution channels, all of which can affect your target market, product, price and reputation. You may need to experiment with a mix of distribution ...

AEP GmbH was the victim of a targeted cyber attack on October 28, which led to the partial encryption of the company's IT systems. The company's own security systems detected the attack. The ...

Cineverse, the film’s distributor, says it put just $500,000 into marketing and promotion for the release. Additional costs to acquire rights were covered by a loan of up to $3.666 million ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a so-called Phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024.